Absci Corp (ABSI)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
CEO:
Sean McClain
Employees:
210
18105 SE MILL PLAIN BLVD, VANCOUVER, WA 98683
(360) 949-1041

Absci Corporation provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Absci was founded in 2011 and is headquartered in Vancouver, Washington.

Data derived from most recent annual or quarterly report
Market Cap 157.87 Million Shares Outstanding92.322 Million Avg 30-day Volume 636.705 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.3
Price to Revenue85.1984 Debt to Equity0.0096 EBITDA-99.773 Million
Price to Book Value1.1128 Operating Margin-1573.3584 Enterprise Value147.861 Million
Current Ratio8.065 EPS Growth0.348 Quick Ratio7.502
1 Yr BETA 1.8672 52-week High/Low 7.04 / 1.13 Profit Margin-2111.2505
Operating Cash Flow Growth-452.3974 Altman Z-Score3.3014 Free Cash Flow to Firm -153.636 Million
Earnings Report2023-08-10
View SEC Filings from ABSI instead.

View recent insider trading info

Absci Corp YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding ABSI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ABSI

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-03-03 by SCHIFFMAN GREGORY T
  • 4: filed on 2023-03-03 by KORMAN SARAH
  • 4: filed on 2023-03-03 by BEDRICK TODD
  • 4: filed on 2023-03-03 by MCCLAIN SEAN
  • 4: filed on 2023-03-03 by BUSCH ANDREAS
  • 4: filed on 2022-11-02 by RABINOVITSJ DANIEL A
  • 3: filed on 2022-11-02 by RABINOVITSJ DANIEL A
  • 4: filed on 2022-10-24 by SCHIFFMAN GREGORY T
  • 4: filed on 2022-10-05 by BUSCH ANDREAS
  • 4: filed on 2022-06-10 by BUSCH ANDREAS

    • Events (8k)

  • 8-K: filed on 2023-03-30:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-10:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2022-12-16:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-02:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-04:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-20:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-08-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-14:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-06-10:
    Item 5.07: Submission of Matters to a Vote of Security Holders

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SCHIFFMAN GREGORY T CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2023-03-01 2

    BUSCH ANDREAS CHIEF INNOVATION OFFICER

    • Officer
    		 0 2023-03-01 3

    BEDRICK TODD SEE REMARKS

    • Officer
    		 0 2023-03-01 2

    KORMAN SARAH CHIEF LEGAL OFFICER

    • Officer
    		 0 2023-03-01 2

    MCCLAIN SEAN SEE REMARKS

    • Officer
    • Director
    		 0 2023-03-01 1

    RABINOVITSJ DANIEL A

    • Director
    		 0 2022-11-01 2

    MCGINNIS KAREN K

    • Director
    		 28,700 2022-06-08 1

    MAGOVCEVIC-LIEBISCH IVANA

    • Director
    		 28,700 2022-06-08 1

    REDMILE GROUP, LLC

    GREEN JEREMY

    • Director
    • 10% Owner
    		 28,700 2022-06-08 1

    CASDIN ELI

    • Director
    		 28,700 2022-06-08 1

    SIROSH JOSEPH

    • Director
    		 11,958 2022-06-08 1

    NAGPAL AMRIT

    • Director
    		 28,700 2022-06-08 1

    JONASSON ZACHARIAH

    • Director
    		 28,700 2022-06-08 1

    WEINSTOCK MATTHEW CHIEF TECHNOLOGY OFFICER

    • Officer
    		 215,000 2022-02-21 0

    PHOENIX VENTURE PARTNERS II LP

    PHOENIX GENERAL PARTNER II LLC

    • 10% Owner
    		 14,492,813 2021-08-13 0

    CASDIN PARTNERS MASTER FUND, L.P.

    CASDIN CAPITAL, LLC

    CASDIN PARTNERS GP, LLC

    CASDIN PRIVATE GROWTH EQUITY FUND, L.P.

    CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC

    • Director
    		 7,718,593 2021-07-26 0

    PIHL ANDREAS CHIEF OPERATING OFFICER

    • Officer
    		 607,937 2021-07-26 0

    REDMILE GROUP, LLC

    REDMILE BIOPHARMA INVESTMENTS II, L.P.

    GREEN JEREMY

    • Director
    • 10% Owner
    		 0 2021-07-21 1

    GOEL NIKHIL CHIEF BUSINESS OFFICER

    • Officer
    		 0 2021-07-21 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ABSCI CORP ABSI 2023-05-29 22:15:04 UTC 2.9332 2.1368 300000
    ABSCI CORP ABSI 2023-05-29 21:45:05 UTC 2.9332 2.1368 300000
    ABSCI CORP ABSI 2023-05-29 21:15:04 UTC 2.9332 2.1368 300000
    ABSCI CORP ABSI 2023-05-29 20:45:04 UTC 2.9332 2.1368 300000
    ABSCI CORP ABSI 2023-05-29 20:15:05 UTC 2.9332 2.1368 300000
    ABSCI CORP ABSI 2023-05-29 19:45:04 UTC 2.9332 2.1368 300000
    ABSCI CORP ABSI 2023-05-29 19:15:04 UTC 2.9332 2.1368 300000
    ABSCI CORP ABSI 2023-05-29 18:45:04 UTC 2.9332 2.1368 300000
    ABSCI CORP ABSI 2023-05-29 18:15:03 UTC 2.9332 2.1368 300000
    ABSCI CORP ABSI 2023-05-29 17:45:04 UTC 2.9332 2.1368 300000
    ABSCI CORP ABSI 2023-05-29 17:15:04 UTC 2.9332 2.1368 300000
    ABSCI CORP ABSI 2023-05-29 16:45:04 UTC 2.9332 2.1368 300000
    ABSCI CORP ABSI 2023-05-29 16:15:03 UTC 2.9332 2.1368 300000
    ABSCI CORP ABSI 2023-05-29 15:45:03 UTC 2.9332 2.1368 300000
    ABSCI CORP ABSI 2023-05-29 15:15:03 UTC 2.9332 2.1368 300000
    ABSCI CORP ABSI 2023-05-29 14:45:05 UTC 2.9332 2.1368 300000
    ABSCI CORP ABSI 2023-05-29 14:15:04 UTC 2.9332 2.1368 300000
    ABSCI CORP ABSI 2023-05-29 13:45:05 UTC 2.9412 2.1288 300000
    ABSCI CORP ABSI 2023-05-29 13:15:03 UTC 2.9412 2.1288 300000
    ABSCI CORP ABSI 2023-05-29 12:45:03 UTC 2.9412 2.1288 300000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund ABSI -12908.0 shares, $-40531.12 2023-01-31 N-PORT
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund ABSI -100.0 shares, $-175.0 2023-03-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments